B Acute Lymphoblastic Leukemia: Clinical Trials

6 trials for B Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 2 recruiting, 1 completed. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Active not recruiting 3, Recruiting 2, Completed 1

Follow B Acute Lymphoblastic Leukemia: new trials by email Literature Review of B Acute Lymphoblastic Leukemia trials Research Report on B Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Biospecimen Collection, Calaspargase Pegol, Levocarnitine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 3Active not recruitingChildren's Oncology Group4402023-08-242026-08-21
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3RecruitingChildren's Oncology Group59512019-10-312026-08-25
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3Active not recruitingNational Cancer Institute (NCI)67202019-07-032026-11-12
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Allopurinol, Cytarabine, Daunorubicin Hydrochloride - B Acute Lymphoblastic Leukemia
Phase 3RecruitingAlliance for Clinical Trials in Oncology3032017-09-202026-11-03
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Calaspargase Pegol, Cyclophosphamide - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia
Phase 3Active not recruitingChildren's Oncology Group3522017-08-082026-10-05
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Clofarabine, Cyclophosphamide, Cytarabine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
Phase 3CompletedNational Cancer Institute (NCI)59492012-02-292026-06-02

Narrower conditions

Burkitt Lymphoma (6)  ·  Leukemia, Biphenotypic, Acute (3)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Down Syndrome (1)

Broader conditions

DNA Virus Infections (6)  ·  Epstein-Barr Virus Infections (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Herpesviridae Infections (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Infections (6)  ·  Lymphatic Diseases (6)  ·  Lymphoma (6)  ·  Lymphoma, B-Cell (6)  ·  Lymphoma, Non-Hodgkin (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Tumor Virus Infections (6)

Interventions

pegaspargase (6)  ·  Cyclophosphamide (5)  ·  Cytarabine (5)  ·  Dexamethasone (5)  ·  Doxorubicin (5)  ·  Mercaptopurine (5)  ·  Methotrexate (5)  ·  Thioguanine (5)  ·  Vincristine (5)  ·  Asparaginase (4)  ·  Calcium Dobesilate (4)  ·  Daunorubicin (4)  ·  Leucovorin (4)  ·  auricularum (4)  ·  azathiopurine (4)

Sponsors

Children's Oncology Group (3)  ·  National Cancer Institute (NCI) (2)  ·  Alliance for Clinical Trials in Oncology (1)

Countries

Canada (6)  ·  United States (6)  ·  Australia (4)  ·  New Zealand (4)  ·  Puerto Rico (4)  ·  Switzerland (2)  ·  Austria (1)  ·  Belgium (1)  ·  Chile (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Ireland (1)

Top investigators

Andrea Biondi (1)  ·  Etan Orgel (1)  ·  Jennifer L McNeer (1)  ·  Lewis B Silverman (1)  ·  Michael J Burke (1)  ·  Sumit Gupta (1)

Results publications

PMID 41671463, PMID 32496902, PMID 32589970, PMID 33844429, PMID 37890117, PMID 39121442, PMID 39651791

NIH funding

U10CA180886 (4), 2017 (1), U10CA098543 (1), U10CA180821 (1), U24CA196173 (1), UG1CA189955 (1)